QR Kodea

THE USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF EBOLA VIRUS DISEASE

Some drugs candidates for treatment of Ebola virus disease (EVD), have been studied, monoclonal antibody (mAb) cocktails have shown great potential as EVD therapeutics. The advantages of mAb therapy include low toxicity, high specificity and versatility, with the range of biological effects being de...

Deskribapen osoa

Gorde:
Egile Nagusiak: T. E. Sizikova, G. V. Borisevich, D. V. Shcheblyakov, D. A. Burmistrova, V. N. Lebedev
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Central Research Institute for Epidemiology 2018-12-01
Saila:Вопросы вирусологии
Gaiak:
review
ebola virus
hemorrhagic fever
drugs
current
monoclonal antibodies
nonhuman primates
Sarrera elektronikoa:https://virusjour.crie.ru/jour/article/viewFile/220/123
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak